Spinal myoclonus following intrathecal administration of diatrizoate meglumine

M C Sam; L Gutmann

doi:10.1111/jon199664256

Back

Spinal myoclonus following intrathecal administration of diatrizoate meglumine

Journal article

Peer reviewed

Spinal myoclonus following intrathecal administration of diatrizoate meglumine

M C Sam and L Gutmann

Journal of neuroimaging, Vol.6(4), pp.256-258

10/1996

DOI: 10.1111/jon199664256

PMID: 8903083

View Online

Abstract

Life-threatening myoclonus developed in a patient following inadvertent intrathecal usage of 60% diatrizoate meglumine. Rhabdomyolysis and myoglobinuria occurred. The patient was successfully treated with midazolam and vecuronium and complete recovery occurred.

Injections, Spinal

Myoglobinuria - chemically induced

Humans

Diatrizoate Meglumine - adverse effects

Male

Hypnotics and Sedatives - therapeutic use

Myoclonus - chemically induced

Spinal Cord Diseases - chemically induced

Contrast Media - adverse effects

Myoclonus - drug therapy

Vecuronium Bromide - therapeutic use

Contrast Media - administration & dosage

Midazolam - therapeutic use

Diatrizoate Meglumine - administration & dosage

Rhabdomyolysis - chemically induced

Aged

Spinal Cord Diseases - drug therapy

Neuromuscular Nondepolarizing Agents - therapeutic use

Details

Title: Subtitle: Spinal myoclonus following intrathecal administration of diatrizoate meglumine
Creators: M C Sam - Department of Neurology, Robert C. Byrd Health Sciences Center, West Virginia University, USA
L Gutmann
Resource Type: Journal article
Publication Details: Journal of neuroimaging, Vol.6(4), pp.256-258
Publisher: United States
DOI: 10.1111/jon199664256
PMID: 8903083
ISSN: 1051-2284
eISSN: 1552-6569
Language: English
Date published: 10/1996
Academic Unit: Neurology
Record Identifier: 9984020894402771

Metrics

9 Record Views

9 Times Cited - Web of Science